BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 27941670)

  • 1. Chromosomal Microarray Analysis of Consecutive Individuals with Autism Spectrum Disorders Using an Ultra-High Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders.
    Ho KS; Wassman ER; Baxter AL; Hensel CH; Martin MM; Prasad A; Twede H; Vanzo RJ; Butler MG
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Performance of an Ultrahigh Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders.
    Ho KS; Twede H; Vanzo R; Harward E; Hensel CH; Martin MM; Page S; Peiffer A; Mowery-Rushton P; Serrano M; Wassman ER
    Biomed Res Int; 2016; 2016():3284534. PubMed ID: 27975050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features.
    Battaglia A; Doccini V; Bernardini L; Novelli A; Loddo S; Capalbo A; Filippi T; Carey JC
    Eur J Paediatr Neurol; 2013 Nov; 17(6):589-99. PubMed ID: 23711909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility and cost-effectiveness analysis of chromosome testing concomitant with chromosomal microarray of patients with constitutional disorders in a U.S. academic medical center.
    Su M; Page S; Haag M; Swisshelm K; Hennerich D; Graw S; LeRoux J; Brzeskiewicz P; Svihovec S; Bao L
    J Genet Couns; 2022 Apr; 31(2):364-374. PubMed ID: 34397147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal Microarray Analysis as a First-Tier Clinical Diagnostic Test in Patients With Developmental Delay/Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies: A Prospective Multicenter Study in Korea.
    Jang W; Kim Y; Han E; Park J; Chae H; Kwon A; Choi H; Kim J; Son JO; Lee SJ; Hong BY; Jang DH; Han JY; Lee JH; Kim SY; Lee IG; Sung IK; Moon Y; Kim M; Park JH
    Ann Lab Med; 2019 May; 39(3):299-310. PubMed ID: 30623622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copy Number Variations in a Cohort of 420 Individuals with Neurodevelopmental Disorders From the South of Brazil.
    Chaves TF; Baretto N; Oliveira LF; Ocampos M; Barbato IT; Anselmi M; De Luca GR; Barbato Filho JH; Pinto LLC; Bernardi P; Maris AF
    Sci Rep; 2019 Nov; 9(1):17776. PubMed ID: 31780800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cohort study of neurodevelopmental disorders and/or congenital anomalies using high resolution chromosomal microarrays in southern Brazil highlighting the significance of ASD.
    Chaves TF; Ocampos M; Barbato IT; de Camargo Pinto LL; de Luca GR; Barbato Filho JH; Bernardi P; Costa Netto Muniz Y; Francesca Maris A
    Sci Rep; 2024 Feb; 14(1):3762. PubMed ID: 38355898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine chromosomal microarray analysis is necessary in Korean patients with unexplained developmental delay/mental retardation/autism spectrum disorder.
    Shin S; Yu N; Choi JR; Jeong S; Lee KA
    Ann Lab Med; 2015 Sep; 35(5):510-8. PubMed ID: 26206688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal Aberrations in Pediatric Patients with Developmental Delay/Intellectual Disability: A Single-Center Clinical Investigation.
    Hu T; Zhang Z; Wang J; Li Q; Zhu H; Lai Y; Wang H; Liu S
    Biomed Res Int; 2019; 2019():9352581. PubMed ID: 31781653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent copy number variations as risk factors for autism spectrum disorders: analysis of the clinical implications.
    Oikonomakis V; Kosma K; Mitrakos A; Sofocleous C; Pervanidou P; Syrmou A; Pampanos A; Psoni S; Fryssira H; Kanavakis E; Kitsiou-Tzeli S; Tzetis M
    Clin Genet; 2016 Jun; 89(6):708-18. PubMed ID: 26777411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of chromosomal microarrays in the evaluation of intellectual disability/global developmental delay patients - A study from a tertiary care genetic centre in India.
    Sharma P; Gupta N; Chowdhury MR; Sapra S; Ghosh M; Gulati S; Kabra M
    Gene; 2016 Sep; 590(1):109-19. PubMed ID: 27291820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of chromosome microarray analysis in patients with unexplained developmental delay/intellectual disability in South China.
    Wang R; Lei T; Fu F; Li R; Jing X; Yang X; Liu J; Li D; Liao C
    Pediatr Neonatol; 2019 Feb; 60(1):35-42. PubMed ID: 29631977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The diagnostic value of chromosome microarray analysis technique in the genetic causes of children with intellectual disability or global developmental delay].
    Wu HR; Li L; Ma YN; Liu CL; Pei P; Zheng XF; Wang ST; Xiao Y; Bu DF; Xu YF; Pan H; Qi Y
    Zhonghua Yi Xue Za Zhi; 2021 Jan; 101(3):224-228. PubMed ID: 33455150
    [No Abstract]   [Full Text] [Related]  

  • 14. Chromosomal microarray testing influences medical management.
    Coulter ME; Miller DT; Harris DJ; Hawley P; Picker J; Roberts AE; Sobeih MM; Irons M
    Genet Med; 2011 Sep; 13(9):770-6. PubMed ID: 21716121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights in the interpretation of array-CGH: autism spectrum disorder and positive family history for intellectual disability predict the detection of pathogenic variants.
    Cappuccio G; Vitiello F; Casertano A; Fontana P; Genesio R; Bruzzese D; Ginocchio VM; Mormile A; Nitsch L; Andria G; Melis D
    Ital J Pediatr; 2016 Apr; 42():39. PubMed ID: 27072107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal microarray analysis of consecutive individuals with autism spectrum disorders or learning disability presenting for genetic services.
    Roberts JL; Hovanes K; Dasouki M; Manzardo AM; Butler MG
    Gene; 2014 Feb; 535(1):70-8. PubMed ID: 24188901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience of chromosomal microarray applied in prenatal and postnatal settings in Hong Kong.
    Cheng SSW; Chan KYK; Leung KKP; Au PKC; Tam WK; Li SKM; Luk HM; Kan ASY; Chung BHY; Lo IFM; Tang MHY
    Am J Med Genet C Semin Med Genet; 2019 Jun; 181(2):196-207. PubMed ID: 30903683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal microarray in postnatal diagnosis of congenital anomalies and neurodevelopmental disorders in Serbian patients.
    Perovic D; Damnjanovic T; Jekic B; Dusanovic-Pjevic M; Grk M; Djuranovic A; Rasic M; Novakovic I; Maksimovic N
    J Clin Lab Anal; 2022 Jun; 36(6):e24441. PubMed ID: 35441737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can clinical characteristics be criteria to perform chromosomal microarray analysis in children and adolescents with autism spectrum disorders?
    Sys M; van den Bogaert A; Roosens B; Lampo A; Jansen A; Wouters S; Keymolen K
    Minerva Pediatr; 2018 Jun; 70(3):225-232. PubMed ID: 27607483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution chromosomal microarray analysis for copy-number variations in high-functioning autism reveals large aberration typical for intellectual disability.
    Werling AM; Grünblatt E; Oneda B; Bobrowski E; Gundelfinger R; Taurines R; Romanos M; Rauch A; Walitza S
    J Neural Transm (Vienna); 2020 Jan; 127(1):81-94. PubMed ID: 31838600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.